Quantcast

Latest Bolus Stories

2014-05-22 20:22:46

QuikCal(TM) Boluses provide critically needed, highly-absorbable calcium in a rapid-release bolus system. OLATHE, Kan. and PHILADELPHIA, May 22, 2014 /PRNewswire-USNewswire/ -- Centaur Animal Health announced today the availability of QuikCal Calcium Boluses for dairy cattle. The bolus features a unique patented delivery system that allows for its easy, safe administration to the cow and rapid release of both calcium chloride and calcium propionate to provide quick blood serum levels...

2011-07-25 06:30:00

BRIDGEWATER, N.J., July 25, 2011 /PRNewswire/ -- Valeritas, Inc., a medical technology company focused on the development and commercialization of innovative drug delivery solutions, announced today it received CE Mark approval for its V-Go(TM) Disposable Insulin Delivery Device as well as ISO 13485: 2003 Quality Management System Certification. The V-Go is designed to provide simple basal-bolus therapy for adults who require insulin therapy. "These are important corporate milestones for...

2011-06-27 06:00:00

SAN MATEO, Calif., June 27, 2011 /PRNewswire/ -- Nile Therapeutics, Inc. (OTCQB: NLTX), a biopharmaceutical company that develops novel therapeutics for heart failure patients, today announced that it has completed dosing the first patient in Part B of the ongoing Phase I study. Part B involves dosing cenderitide with Medtronic's insulin pump technology. The trial is being conducted pursuant to Nile's previously announced collaboration with Medtronic and is the first clinical step towards...

2011-03-11 08:43:35

(Ivanhoe Newswire) -- A new study shows there are no significant differences in how heart failure patients fare when they're given diuretic therapy in one dose or continuously. For the study, more than 300 patients with acute heart failure received furosemide (Lasix), which is the most commonly-used diuretic for heart failure. They were randomly assigned to receive the drug intravenously by a bolus every 12 hours or by a continuous infusion. Both groups received high and low doses. Results...

2011-03-01 06:30:00

BRIDGEWATER, N.J., March 1, 2011 /PRNewswire/ -- Valeritas, Inc., a medical technology company committed to the development and commercialization of innovative drug delivery solutions, announced today that the U.S. Food and Drug Administration has cleared the company's V-Go Disposable Insulin Delivery Device for use with Novo Nordisk's NovoLog® for the continuous subcutaneous delivery of insulin in preset basal rates and with on-demand bolus dosing for adult patients...

2010-11-15 11:00:00

BASKING RIDGE, N.J., Nov. 15, 2010 /PRNewswire/ -- Regado Biosciences, Inc., a privately held company leading the development of antithrombotic aptamers with active control agents, announced today two abstract presentations evaluating the potency and duration of a subcutaneous depot formulation of pegnivacogin (a.k.a. RB006), a nuclease-stabilized aptamer and direct Factor IXa inhibitor. The studies were presented at the American Heart Association (AHA) Scientific Sessions meeting, on...

2010-06-25 15:20:00

PARIS, June 25 /PRNewswire-FirstCall/ -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that results from the RAndomized Study of Basal Bolus Insulin Therapy in the Inpatient Management of Patients with Type 2 Diabetes Undergoing General Surgery (RABBIT-2 Surgery) found that treatment with a basal-bolus regimen that included Lantus® (insulin glargine [rDNA origin] injection) once-daily and Apidra® (insulin glulisine [rDNA origin] injection)...

2010-03-17 08:25:00

BRIDGEWATER, N.J., March 17 /PRNewswire/ -- Valeritas, Inc., a medical technology company committed to the development and commercialization of innovative drug delivery solutions, announced today that it has hired James E. Dentzer to serve as its Chief Financial Officer. Dentzer brings a wealth of experience to Valeritas, with his most recent success as Chief Financial Officer of Amicus Therapeutics where he led the company in closing a Series D private financing and executing a...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related